Trademark: 88647386
Status Date
Tuesday, January 19, 2021
Registration Number
6252399
Registration Date
Tuesday, January 19, 2021
Filing Date
Wednesday, October 9, 2019
Published for Opposition
Tuesday, May 12, 2020
5 Pharmaceutical preparations for the treatment of the central nervous system disorders; pharmaceutical preparations for the treatment of Parkinson's disease, Alzheimer's disease, depression, anxiety, movement disorders, memory impairment, brain disorder and brain dysfunction
Color is not claimed as a feature of the mark.
The mark consists of two layers of overlapping connected droplets.
Jan 19, 2021
Registered-Principal Register
Dec 15, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Dec 14, 2020
Allowed Principal Register - Sou Accepted
Nov 25, 2020
Statement Of Use Processing Complete
Nov 16, 2020
Use Amendment Filed
Nov 25, 2020
Case Assigned To Intent To Use Paralegal
Nov 16, 2020
Teas Statement Of Use Received
Jul 7, 2020
Noa E-Mailed - Sou Required From Applicant
May 12, 2020
Official Gazette Publication Confirmation E-Mailed
May 12, 2020
Published For Opposition
Apr 22, 2020
Notification Of Notice Of Publication E-Mailed
Apr 1, 2020
Approved For Pub - Principal Register
Mar 18, 2020
Teas/Email Correspondence Entered
Mar 18, 2020
Correspondence Received In Law Office
Mar 18, 2020
Teas Response To Office Action Received
Jan 15, 2020
Notification Of Non-Final Action E-Mailed
Jan 15, 2020
Non-Final Action E-Mailed
Jan 15, 2020
Non-Final Action Written
Jan 13, 2020
Assigned To Examiner
Oct 25, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 25, 2019
Teas Change Of Owner Address Received
Oct 16, 2019
Notice Of Design Search Code E-Mailed
Oct 15, 2019
New Application Office Supplied Data Entered In Tram
Oct 12, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
